Loading…

The artificial pancreas: current status and future prospects in the management of diabetes

Recent advances in insulins, insulin pumps, continuous glucose‐monitoring systems, and control algorithms have resulted in an acceleration of progress in the development of artificial pancreas devices. This review discusses progress in the development of external systems that are based on subcutaneo...

Full description

Saved in:
Bibliographic Details
Published in:Annals of the New York Academy of Sciences 2014-04, Vol.1311 (1), p.102-123
Main Authors: Peyser, Thomas, Dassau, Eyal, Breton, Marc, Skyler, Jay S.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5301-39320f3480f53b6a4238bef7e43b218debfb57d8c7439dadf65aa3df618eced73
cites cdi_FETCH-LOGICAL-c5301-39320f3480f53b6a4238bef7e43b218debfb57d8c7439dadf65aa3df618eced73
container_end_page 123
container_issue 1
container_start_page 102
container_title Annals of the New York Academy of Sciences
container_volume 1311
creator Peyser, Thomas
Dassau, Eyal
Breton, Marc
Skyler, Jay S.
description Recent advances in insulins, insulin pumps, continuous glucose‐monitoring systems, and control algorithms have resulted in an acceleration of progress in the development of artificial pancreas devices. This review discusses progress in the development of external systems that are based on subcutaneous drug delivery and subcutaneous continuous glucose monitoring. There are two major system‐level approaches to achieving closed‐loop control of blood glucose in diabetic individuals. The unihormonal approach uses insulin to reduce blood glucose and relies on complex safety mitigation algorithms to reduce the risk of hypoglycemia. The bihormonal approach uses both insulin to lower blood glucose and glucagon to raise blood glucose, and also relies on complex algorithms to provide for safety of the user. There are several major strategies for the design of control algorithms and supervision control for application to the artificial pancreas: proportional–integral–derivative, model predictive control, fuzzy logic, and safety supervision designs. Advances in artificial pancreas research in the first decade of this century were based on the ongoing computer revolution and miniaturization of electronic technology. The advent of modern smartphones has created the ability to utilize smartphone technology as the engineering centerpiece of an artificial pancreas. With these advances, an artificial or bionic pancreas is within reach.
doi_str_mv 10.1111/nyas.12431
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1541431534</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1541431534</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5301-39320f3480f53b6a4238bef7e43b218debfb57d8c7439dadf65aa3df618eced73</originalsourceid><addsrcrecordid>eNqN0c1u1DAUBWALgei0sOEBkCU2qFKK_xI77KqqLRXVsKAI6Ma6ca7BJckMtiOYt8fTabtggfDGm-8e2fcQ8oKzI17Om2kD6YgLJfkjsuBatVXTSPGYLBjTujKtkHtkP6UbxrgwSj8le0JpUXPVLsj11XekEHPwwQUY6BomFxHSW-rmGHHKNGXIc6Iw9dTPeY5I13GV1uhyomGiucyPMME3HLd65WkfoMOM6Rl54mFI-PzuPiCfzk6vTt5Vlx_OL06OLytXS8Yr2UrBvFSG-Vp2DSghTYdeo5Kd4KbHzne17o3TSrY99L6pAWS5uEGHvZYH5PUut7zr54wp2zEkh8MAE67mZHmteNlNLdV_UN4oxlrdFvrqL3qzmuNUPrJVygjGjSnqcKdc2UmK6O06hhHixnJmt-XYbTn2tpyCX95Fzt2I_QO9b6MAvgO_woCbf0TZ5dfjj_eh1W4mpIy_H2Yg_rCNlrq2n5fndtm-X7JrruwX-QeyJqi_</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1514820188</pqid></control><display><type>article</type><title>The artificial pancreas: current status and future prospects in the management of diabetes</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Peyser, Thomas ; Dassau, Eyal ; Breton, Marc ; Skyler, Jay S.</creator><creatorcontrib>Peyser, Thomas ; Dassau, Eyal ; Breton, Marc ; Skyler, Jay S.</creatorcontrib><description>Recent advances in insulins, insulin pumps, continuous glucose‐monitoring systems, and control algorithms have resulted in an acceleration of progress in the development of artificial pancreas devices. This review discusses progress in the development of external systems that are based on subcutaneous drug delivery and subcutaneous continuous glucose monitoring. There are two major system‐level approaches to achieving closed‐loop control of blood glucose in diabetic individuals. The unihormonal approach uses insulin to reduce blood glucose and relies on complex safety mitigation algorithms to reduce the risk of hypoglycemia. The bihormonal approach uses both insulin to lower blood glucose and glucagon to raise blood glucose, and also relies on complex algorithms to provide for safety of the user. There are several major strategies for the design of control algorithms and supervision control for application to the artificial pancreas: proportional–integral–derivative, model predictive control, fuzzy logic, and safety supervision designs. Advances in artificial pancreas research in the first decade of this century were based on the ongoing computer revolution and miniaturization of electronic technology. The advent of modern smartphones has created the ability to utilize smartphone technology as the engineering centerpiece of an artificial pancreas. With these advances, an artificial or bionic pancreas is within reach.</description><identifier>ISSN: 0077-8923</identifier><identifier>EISSN: 1749-6632</identifier><identifier>DOI: 10.1111/nyas.12431</identifier><identifier>PMID: 24725149</identifier><identifier>CODEN: ANYAA9</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Algorithms ; artificial pancreas ; Blood ; continuous glucose monitoring ; Control theory ; Diabetes Mellitus, Type 1 - drug therapy ; Diabetes Mellitus, Type 1 - surgery ; Glucose ; Humans ; Hypoglycemic Agents - therapeutic use ; Insulin ; Insulin - therapeutic use ; insulin infusion ; Insulin Infusion Systems ; Mathematical models ; Monitoring systems ; Pancreas ; Pancreas, Artificial ; Safety ; Smartphones</subject><ispartof>Annals of the New York Academy of Sciences, 2014-04, Vol.1311 (1), p.102-123</ispartof><rights>2014 New York Academy of Sciences.</rights><rights>2014 The New York Academy of Sciences</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5301-39320f3480f53b6a4238bef7e43b218debfb57d8c7439dadf65aa3df618eced73</citedby><cites>FETCH-LOGICAL-c5301-39320f3480f53b6a4238bef7e43b218debfb57d8c7439dadf65aa3df618eced73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24725149$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Peyser, Thomas</creatorcontrib><creatorcontrib>Dassau, Eyal</creatorcontrib><creatorcontrib>Breton, Marc</creatorcontrib><creatorcontrib>Skyler, Jay S.</creatorcontrib><title>The artificial pancreas: current status and future prospects in the management of diabetes</title><title>Annals of the New York Academy of Sciences</title><addtitle>Ann. N.Y. Acad. Sci</addtitle><description>Recent advances in insulins, insulin pumps, continuous glucose‐monitoring systems, and control algorithms have resulted in an acceleration of progress in the development of artificial pancreas devices. This review discusses progress in the development of external systems that are based on subcutaneous drug delivery and subcutaneous continuous glucose monitoring. There are two major system‐level approaches to achieving closed‐loop control of blood glucose in diabetic individuals. The unihormonal approach uses insulin to reduce blood glucose and relies on complex safety mitigation algorithms to reduce the risk of hypoglycemia. The bihormonal approach uses both insulin to lower blood glucose and glucagon to raise blood glucose, and also relies on complex algorithms to provide for safety of the user. There are several major strategies for the design of control algorithms and supervision control for application to the artificial pancreas: proportional–integral–derivative, model predictive control, fuzzy logic, and safety supervision designs. Advances in artificial pancreas research in the first decade of this century were based on the ongoing computer revolution and miniaturization of electronic technology. The advent of modern smartphones has created the ability to utilize smartphone technology as the engineering centerpiece of an artificial pancreas. With these advances, an artificial or bionic pancreas is within reach.</description><subject>Algorithms</subject><subject>artificial pancreas</subject><subject>Blood</subject><subject>continuous glucose monitoring</subject><subject>Control theory</subject><subject>Diabetes Mellitus, Type 1 - drug therapy</subject><subject>Diabetes Mellitus, Type 1 - surgery</subject><subject>Glucose</subject><subject>Humans</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Insulin</subject><subject>Insulin - therapeutic use</subject><subject>insulin infusion</subject><subject>Insulin Infusion Systems</subject><subject>Mathematical models</subject><subject>Monitoring systems</subject><subject>Pancreas</subject><subject>Pancreas, Artificial</subject><subject>Safety</subject><subject>Smartphones</subject><issn>0077-8923</issn><issn>1749-6632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqN0c1u1DAUBWALgei0sOEBkCU2qFKK_xI77KqqLRXVsKAI6Ma6ca7BJckMtiOYt8fTabtggfDGm-8e2fcQ8oKzI17Om2kD6YgLJfkjsuBatVXTSPGYLBjTujKtkHtkP6UbxrgwSj8le0JpUXPVLsj11XekEHPwwQUY6BomFxHSW-rmGHHKNGXIc6Iw9dTPeY5I13GV1uhyomGiucyPMME3HLd65WkfoMOM6Rl54mFI-PzuPiCfzk6vTt5Vlx_OL06OLytXS8Yr2UrBvFSG-Vp2DSghTYdeo5Kd4KbHzne17o3TSrY99L6pAWS5uEGHvZYH5PUut7zr54wp2zEkh8MAE67mZHmteNlNLdV_UN4oxlrdFvrqL3qzmuNUPrJVygjGjSnqcKdc2UmK6O06hhHixnJmt-XYbTn2tpyCX95Fzt2I_QO9b6MAvgO_woCbf0TZ5dfjj_eh1W4mpIy_H2Yg_rCNlrq2n5fndtm-X7JrruwX-QeyJqi_</recordid><startdate>201404</startdate><enddate>201404</enddate><creator>Peyser, Thomas</creator><creator>Dassau, Eyal</creator><creator>Breton, Marc</creator><creator>Skyler, Jay S.</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7ST</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>SOI</scope><scope>7X8</scope><scope>7SP</scope><scope>7U5</scope><scope>L7M</scope></search><sort><creationdate>201404</creationdate><title>The artificial pancreas: current status and future prospects in the management of diabetes</title><author>Peyser, Thomas ; Dassau, Eyal ; Breton, Marc ; Skyler, Jay S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5301-39320f3480f53b6a4238bef7e43b218debfb57d8c7439dadf65aa3df618eced73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Algorithms</topic><topic>artificial pancreas</topic><topic>Blood</topic><topic>continuous glucose monitoring</topic><topic>Control theory</topic><topic>Diabetes Mellitus, Type 1 - drug therapy</topic><topic>Diabetes Mellitus, Type 1 - surgery</topic><topic>Glucose</topic><topic>Humans</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Insulin</topic><topic>Insulin - therapeutic use</topic><topic>insulin infusion</topic><topic>Insulin Infusion Systems</topic><topic>Mathematical models</topic><topic>Monitoring systems</topic><topic>Pancreas</topic><topic>Pancreas, Artificial</topic><topic>Safety</topic><topic>Smartphones</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Peyser, Thomas</creatorcontrib><creatorcontrib>Dassau, Eyal</creatorcontrib><creatorcontrib>Breton, Marc</creatorcontrib><creatorcontrib>Skyler, Jay S.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Environment Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>Environment Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Electronics &amp; Communications Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><jtitle>Annals of the New York Academy of Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Peyser, Thomas</au><au>Dassau, Eyal</au><au>Breton, Marc</au><au>Skyler, Jay S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The artificial pancreas: current status and future prospects in the management of diabetes</atitle><jtitle>Annals of the New York Academy of Sciences</jtitle><addtitle>Ann. N.Y. Acad. Sci</addtitle><date>2014-04</date><risdate>2014</risdate><volume>1311</volume><issue>1</issue><spage>102</spage><epage>123</epage><pages>102-123</pages><issn>0077-8923</issn><eissn>1749-6632</eissn><coden>ANYAA9</coden><abstract>Recent advances in insulins, insulin pumps, continuous glucose‐monitoring systems, and control algorithms have resulted in an acceleration of progress in the development of artificial pancreas devices. This review discusses progress in the development of external systems that are based on subcutaneous drug delivery and subcutaneous continuous glucose monitoring. There are two major system‐level approaches to achieving closed‐loop control of blood glucose in diabetic individuals. The unihormonal approach uses insulin to reduce blood glucose and relies on complex safety mitigation algorithms to reduce the risk of hypoglycemia. The bihormonal approach uses both insulin to lower blood glucose and glucagon to raise blood glucose, and also relies on complex algorithms to provide for safety of the user. There are several major strategies for the design of control algorithms and supervision control for application to the artificial pancreas: proportional–integral–derivative, model predictive control, fuzzy logic, and safety supervision designs. Advances in artificial pancreas research in the first decade of this century were based on the ongoing computer revolution and miniaturization of electronic technology. The advent of modern smartphones has created the ability to utilize smartphone technology as the engineering centerpiece of an artificial pancreas. With these advances, an artificial or bionic pancreas is within reach.</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>24725149</pmid><doi>10.1111/nyas.12431</doi><tpages>22</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0077-8923
ispartof Annals of the New York Academy of Sciences, 2014-04, Vol.1311 (1), p.102-123
issn 0077-8923
1749-6632
language eng
recordid cdi_proquest_miscellaneous_1541431534
source Wiley-Blackwell Read & Publish Collection
subjects Algorithms
artificial pancreas
Blood
continuous glucose monitoring
Control theory
Diabetes Mellitus, Type 1 - drug therapy
Diabetes Mellitus, Type 1 - surgery
Glucose
Humans
Hypoglycemic Agents - therapeutic use
Insulin
Insulin - therapeutic use
insulin infusion
Insulin Infusion Systems
Mathematical models
Monitoring systems
Pancreas
Pancreas, Artificial
Safety
Smartphones
title The artificial pancreas: current status and future prospects in the management of diabetes
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T02%3A56%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20artificial%20pancreas:%20current%20status%20and%20future%20prospects%20in%20the%20management%20of%20diabetes&rft.jtitle=Annals%20of%20the%20New%20York%20Academy%20of%20Sciences&rft.au=Peyser,%20Thomas&rft.date=2014-04&rft.volume=1311&rft.issue=1&rft.spage=102&rft.epage=123&rft.pages=102-123&rft.issn=0077-8923&rft.eissn=1749-6632&rft.coden=ANYAA9&rft_id=info:doi/10.1111/nyas.12431&rft_dat=%3Cproquest_cross%3E1541431534%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5301-39320f3480f53b6a4238bef7e43b218debfb57d8c7439dadf65aa3df618eced73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1514820188&rft_id=info:pmid/24725149&rfr_iscdi=true